LDL Cholesterol

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Another Downer For Merck's Cholesterol Drugs

Published July 9, 2009, 9:49 pm, Forbes

Why investors are right to worry that a new study could damage the company's outlook.

Discover News | Full Story


Healthbeat Report: Cholesterol filtering

Published July 9, 2009, 9:17 pm, ABC 7 Chicago

Find out about an alternative treatment for high cholesterol.

Discover News | Full Story


Blood vessel bends and branches put the brakes on statins

Published July 9, 2009, 4:00 pm, PRWeb via Yahoo! News

First evidence that biomechanical forces may affect drug's action.

Discover News | Full Story


Merck Falls After Study of Cholesterol Drugs Halted (Update3)

Published July 9, 2009, 2:29 pm, Bloomberg

July 9 (Bloomberg) -- Merck & Co. fell in New York trading after researchers halted a study comparing Abbott Laboratories ’ cholesterol drug Niaspan with Zetia, sold by Merck and Schering- Plough Corp .

Discover News | Full Story


(AFX UK Focus) 2009-07-09 20:44 UPDATE 3-Merck shares fall on cholesterol study concerns

Published July 9, 2009, 1:07 pm, Interactive Investor

By Lewis Krauskopf

Discover News | Full Story


(AFX UK Focus) 2009-07-09 20:32 UPDATE 3-Merck shares fall on cholesterol study concerns

Published July 9, 2009, 12:52 pm, Interactive Investor

By Lewis Krauskopf

Discover News | Full Story


Merck Falls After Study of Cholesterol Drugs Halted (Update2)

Published July 9, 2009, 11:13 am, Bloomberg

July 9 (Bloomberg) -- Merck & Co. fell the most in almost three months in New York trading after a study was halted comparing Abbott Laboratories ’ cholesterol drug Niaspan with Zetia, sold by Merck and Schering-Plough Corp .

Discover News | Full Story


Aetna Pilot Helps Physicians Improve Care For Diabetics

Published July 9, 2009, 10:14 am, Medical News Today

Aetna (NYSE: AET) and Total Therapeutic Management (TTM) announced the results of a pilot program in Southeastern Pennsylvania and South Florida that improved patient care and increased the number of physicians recognized by the National Committee for Quality Assurance (NCQA) Diabetes Physician Recognition Program. Funded by Amylin Pharmaceuticals, Inc.

Discover News | Full Story


Abbott Study of Niaspan Against Merck’s Zetia Halted (Update1)

Published July 9, 2009, 8:30 am, Bloomberg

July 9 (Bloomberg) -- A study comparing Abbott Laboratories ’ cholesterol drug Niaspan with Merck & Co. and Schering-Plough Corp.’s Zetia was ended early, for reasons unrelated to patients’ safety.

Discover News | Full Story


Amarin Receives Special Protocol Assessment Agreement from the FDA for Phase 3 Trial in Mixed Dyslipidemia

Published July 9, 2009, 5:42 am, Business Wire via Yahoo! Finance

DUBLIN----Amarin Corporation plc today announced that it has reached agreement with the U.S. Food and Drug Administration under a Special Protocol Assessment for its planned Phase 3 clinical trial of AMR101 in patients with mixed dyslipidemia.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a